CJ Launches Domestic Sale of SSI's Tuberculosis Vaccine

Published: 2005-01-13 06:57:00

Updated: 2005-01-13 06:57:00

CJ Pharmaceutical Division said, effective January 1st, it has launched the domestic sale of BCG Vaccine SSI, under an exclusive distribution agreement made last year with Denmark-based Statens Serum Institute (SSI).According to a company marketing representative, BCG Vaccine SSI is used for acti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK